Furthermore, as a 5-HT transporter, SLC6A4 is a critical target of the major depressive episode (Consoloni et al., 2018), and this protein may serve as a novel therapeutic target for PTSD (Lam et al., 2018). Here, SLC6A4 is linked to major depressive episode.